share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：拟议出售证券
美股sec公告 ·  05/02 10:48
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 05/02/2024, with an aggregate market value of $423,500. The shares to be sold were acquired through various means, including stock option exercises on 08/02/2023 and 11/01/2023, restricted stock vesting on 08/15/2023, and as founder's shares on 09/01/2016. The transactions for acquiring these shares involved payments in cash and as compensation. This planned sale follows a series of transactions over the past three months, where a total of 354,591 shares were sold for gross proceeds of $3,368,336.79. The notice for the upcoming sale was filed on the same day as the planned sale, with the sale plan having been adopted on 12/27/2023.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 05/02/2024, with an aggregate market value of $423,500. The shares to be sold were acquired through various means, including stock option exercises on 08/02/2023 and 11/01/2023, restricted stock vesting on 08/15/2023, and as founder's shares on 09/01/2016. The transactions for acquiring these shares involved payments in cash and as compensation. This planned sale follows a series of transactions over the past three months, where a total of 354,591 shares were sold for gross proceeds of $3,368,336.79. The notice for the upcoming sale was filed on the same day as the planned sale, with the sale plan having been adopted on 12/27/2023.
Recursion Pharmicals, Inc.高管兼董事克里斯托弗·吉布森定于2024年2月5日出售5万股A类股票，总市值为423,500美元。待出售的股票是通过各种方式收购的，包括2023年2月8日和2023年1月11日的股票期权行使，2023年8月15日的限制性股票归属，以及2016年1月9日作为创始人的股票进行收购。收购这些股份的交易涉及现金支付和补偿。此次计划出售是在过去三个月进行的一系列交易之后进行的，共出售了354,591股股票，总收益为3,368,336.79美元。即将进行的销售的通知是在计划销售的同一天提交的，销售计划已于2023年12月27日通过。
Recursion Pharmicals, Inc.高管兼董事克里斯托弗·吉布森定于2024年2月5日出售5万股A类股票，总市值为423,500美元。待出售的股票是通过各种方式收购的，包括2023年2月8日和2023年1月11日的股票期权行使，2023年8月15日的限制性股票归属，以及2016年1月9日作为创始人的股票进行收购。收购这些股份的交易涉及现金支付和补偿。此次计划出售是在过去三个月进行的一系列交易之后进行的，共出售了354,591股股票，总收益为3,368,336.79美元。即将进行的销售的通知是在计划销售的同一天提交的，销售计划已于2023年12月27日通过。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息